Please assess the completion status of the following clinical trial:

Trial Title: Continuous Thoracic Paravertebral Analgesia for Video-assisted Thoracoscopic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for an elective or emergency VATS surgery (lobectomy or bilobectomy)~* Patients eligible for fast-track surgery~* American Society of Anesthesiologists (ASA) physical status from 1 to 3~Exclusion Criteria:~* Contraindication to paravertebral nerve blockade~* Severe hepatic insufficiency~* Renal insufficiency~* Known allergy to local anesthetics, morphine or hydromorphone~* Contraindication to acetaminophen or non-steroidal anti-inflammatory drugs (NSAID)~* Inability to understand a verbal numeric pain scale despite previous instruction~* Inability to understand the instructions and precautions related to the use of a portable infusion pump or absence of a resource person or natural caregiver at home~* Preexisting pain at the site where the surgical incision will be made~* Current use of opioids, anticonvulsants or tricyclic antidepressants~* Recent history of drug or opioid abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Paravertebral analgesia (Type: EXPERIMENTAL): A paravertebral nerve block will be performed under ultrasound guidance by the anaesthesiologist prior to the induction of general anesthesia. A catheter will be inserted and a continuous infusion of bupivacaine will be administered.
- Intercostal analgesia (Type: ACTIVE_COMPARATOR): An intercostal nerve block using a single dose of bupivacaine will be performed by the surgeon at the end of surgery before skin closure.

Based on this trial design, predict the completion outcome and termination type (if applicable).